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Background: The clinical outcomes of zotarolimus-eluting stent (ZES, Endeavor Resolute) for long coronary lesions are not clear yet, although 
sirolimus-eluting stent (SES, Cypher) showed favorable effects for such lesions. We compared the clinical outcomes of these two drug-eluting stents 
for long coronary lesions. 
Methods: We analyzed the medical and angiographic records of 304 lesions in 261 patients who were treated with ZES and 290 lesions in 259 
patients who were treated with SES for long coronary lesions (stent length ≥ 30mm). Each patient was treated with same kind of stent, if they need 
multiple stents implantation. 
Results: Baseline and procedural characteristics of the 2 groups were similar. However, more patients in ZES group underwent stent implantation 
due to acute myocardial infarction (MI) than SES group (28.6% vs. 21.4%, p=0.042). Follow-up coronary angiography was done in 56.6% of ZES 
group and 56.9% of SES group (p=0.938). The cumulative probabilities of major adverse cardiac events, a composite of cardiac death, MI and target 
vessel revascularization, at 2 years after stent implantation were similar between the 2 groups (5.7% vs. 5.4%, p=0.862). However, the cumulative 
probability of stent thrombosis at 2 years after stent implantation was significantly lower in ZES group (0.0% vs. 1.5%, p= 0.042). 
Conclusions: ZES showed non-inferior clinical outcomes for long coronary lesions when compared to SES. Furthermore, the probability of stent 
thrombosis was significantly lower in ZES group. 
